Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2020-01, Vol.45 (1), p.234-235
Hauptverfasser:	Bhattacharya, Anindya, Ceusters, Marc
Format:	Artikel
Sprache:	eng
Schlagworte:	Addictions Alzheimer's disease Animals Antagonists Binding sites Brain - diagnostic imaging Brain - drug effects Brain - metabolism Brain research Cocaine Comorbidity Dosimetry Drug Delivery Systems - methods Drug dosages Hot Topics Human subjects Humans Inflammation Inflammation - diagnostic imaging Inflammation - drug therapy Inflammation - metabolism Laboratories Ligands Mental disorders Mental Disorders - diagnostic imaging Mental Disorders - drug therapy Mental Disorders - metabolism Narcotics Nervous System Diseases - diagnostic imaging Nervous System Diseases - drug therapy Nervous System Diseases - metabolism Neurosciences Psychosis Purinergic P2X Receptor Antagonists - administration & dosage Purinergic P2X Receptor Antagonists - metabolism R&D Research & development
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!